Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2002
11/05/2002US6475788 Anti-bacterial antibodies and methods of use
11/05/2002US6475787 Method for producing monoclonal antibodies
11/05/2002US6475766 Human osteoclast-derived cathepsin
11/05/2002US6475763 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
11/05/2002US6475753 94 Human Secreted Proteins
11/05/2002US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound
11/05/2002US6475741 Antiinflammatory agents
11/05/2002US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002US6475547 Immunoglobulin-rich milk, production and use thereof
11/05/2002US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O
11/05/2002US6475486 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
11/05/2002US6475485 Two novel human cathepsin proteins
11/05/2002CA2066777C Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection
11/05/2002CA2011833C Novel polypeptide and production thereof
11/04/2002EP1163324A4 Genetically modified plants having modulated brassinosteroid signaling
11/04/2002EP0904109A4 Targeting macromolecular prodrugs to t lymphocytes
10/2002
10/31/2002WO2002086508A2 Elisa kit for the determination of cyp2c19 metabolic phenotypes and uses thereof
10/31/2002WO2002086443A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002WO2002086123A2 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/31/2002WO2002086113A2 Enzyme and snp marker for disease
10/31/2002WO2002086102A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002WO2002086096A2 Methods of producing or identifying intrabodies in eukaryotic cells
10/31/2002WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002WO2002086087A2 Cytokine protein family
10/31/2002WO2002086085A2 Human timp-1 antibodies
10/31/2002WO2002086083A2 Methods of enhancing cell responsiveness
10/31/2002WO2002086082A2 Isolation of neural stem cells using gangliosides and other surface markers
10/31/2002WO2002086079A2 T1r3 a novel taste receptor
10/31/2002WO2002086070A2 Binding molecules for fc-region polypeptides
10/31/2002WO2002086069A2 Secreted proteins
10/31/2002WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
10/31/2002WO2002085946A1 Bispecific antibodies that bind trail-r1 and trail-r2
10/31/2002WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002WO2002085924A2 ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE
10/31/2002WO2002085300A2 Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
10/31/2002WO2002085093A2 Replikin peptides and uses thereof
10/31/2002WO2002068585A3 Tip39 polypeptides
10/31/2002WO2002068475A3 Pharmaceutical composition of f(ab)2 fragments of antibodies and method for the preparation thereof
10/31/2002WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002WO2002064022A3 Therapy for cerebral vasospasm
10/31/2002WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002WO2002058628A3 Immunotherapeutic methods for extracorporeal modulation of cd36 and its ligands
10/31/2002WO2002046219A3 Rho-gtpase activating proteins and methods related thereto
10/31/2002WO2002042455A3 Modifier of organelle metalbolism
10/31/2002WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002WO2002032946A3 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
10/31/2002WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
10/31/2002WO2002014499A3 Claudin polypeptides
10/31/2002WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses
10/31/2002WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001060156A9 Neutralizing antibody and immunomodulatory enhancing compositions
10/31/2002WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002WO2001058479A9 Immunotherapy using interleukin 13 receptor subunit alpha 2
10/31/2002WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002US20020162129 Prevention and treatment of alzheimer's disease
10/31/2002US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
10/31/2002US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002US20020161202 For modulating apoptosis in mammalian cells
10/31/2002US20020161201 For use in cancer diagnosis and therapy
10/31/2002US20020161200 For therapy
10/31/2002US20020161198 Used for determining the amount of hLH beta cf or hLH beta cf-related molecule in a sample
10/31/2002US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002US20020161191 Novel Imidazoline receptor homologs
10/31/2002US20020160974 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/31/2002US20020160959 Therapeutic compounds for ovarian cancer
10/31/2002US20020160957 Treating tumors
10/31/2002US20020160954 Polynucleotides; Interphotoreceptor matrix component (IPMC) gene family; treating eye disorders
10/31/2002US20020160953 Mammalian glycoprotein hormone-1
10/31/2002US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002US20020160933 Methods and compositions for producing a neurosalutary effect in a subject
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160477 CAF1-related protein
10/31/2002US20020160476 Genetic engineeering; binding to antibodies
10/31/2002US20020160474 Adipocyte complement related protein zacrp11
10/31/2002US20020160473 Far red shifted fluorescent proteins
10/31/2002US20020160463 Phagemid for antibody screening
10/31/2002US20020160456 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/31/2002US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002US20020160447 Ups (ugc)
10/31/2002US20020160433 Diagnosis of urogenital disorders
10/31/2002US20020160432 Quantitative analysis; diagnosis of infections
10/31/2002US20020160429 Using antibody released by hybridomas cells
10/31/2002US20020160425 Process for differential diagnosis of Alzheimer's dementia and device therefor
10/31/2002US20020160397 Measuring variations; calibration
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 1494